PeriphEX Corp. develops products intended to alleviate the symptoms of Peripheral Neuropathy using a proprietary technology based on nanobubbles of Oxygen (O2) and Carbon Dioxide (CO2). Outcomes of clinical evaluations of the product appear to be significantly more effective than the main drugs on the market and no side effects or complications have been seen so far.
Looking for a particular PeriphEX Corp. employee's phone or email?
The PeriphEX Corp. annual revenue was $200000 in 2026.
PeriphEX Corp. is based in Austin, Texas.
The NAICS codes for PeriphEX Corp. are [42421, 424, 4242, 42].
The SIC codes for PeriphEX Corp. are [512, 51].